![William Gannon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
William Gannon
Président chez
The Foundation For Sickle Cell Research
Profil
William E.
Gannon is currently the Chairman at The Foundation For Sickle Cell Research.
He is also a Member at Regulatory Affairs Professionals Society, Drug Information Association, and American Academy of Pharmaceutical Physicians.
Previously, he served as the Chief Scientific Officer & Medical Director at Protalex, Inc. and Capital City Technical Consulting, Inc. He also held the position of Vice President-Medical & Regulatory Affairs at CASI Pharmaceuticals, Inc. and Vice President-Regulatory Affairs at Genprex, Inc. Dr. Gannon obtained an MBA from George Washington University in 1988.
Postes actifs de William Gannon
| Sociétés | Poste | Début |
|---|---|---|
The Foundation For Sickle Cell Research | Président | 03/04/2014 |
Regulatory Affairs Professionals Society
 Regulatory Affairs Professionals Society Miscellaneous Commercial ServicesCommercial Services Operates as NPO that offers healthcare products | Corporate Officer/Principal | - |
American Academy of Pharmaceutical Physicians | Corporate Officer/Principal | - |
Drug Information Association
 Drug Information Association Miscellaneous Commercial ServicesCommercial Services Operates as non-profit multidisciplinary association for health and well-being | Corporate Officer/Principal | - |
Anciens postes connus de William Gannon
| Sociétés | Poste | Fin |
|---|---|---|
Capital City Technical Consulting, Inc. | Directeur Technique/Scientifique/R&D | 22/08/2023 |
| GENPREX, INC. | Conseiller Juridique Général | - |
| PROTALEX, INC. | Directeur Technique/Scientifique/R&D | - |
CASI Pharmaceuticals, Inc. /Old/
 CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs for treating cancer and inflammatory diseases | Directeur Technique/Scientifique/R&D | - |
Formation de William Gannon
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
96
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
CASI Pharmaceuticals, Inc. /Old/
CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs for treating cancer and inflammatory diseases | Health Technology |
Protalex, Inc.
 Protalex, Inc. Pharmaceuticals: MajorHealth Technology Develops and supplies drugs for autoimmune and inflammatory diseases | Health Technology |
Regulatory Affairs Professionals Society
Regulatory Affairs Professionals Society Miscellaneous Commercial ServicesCommercial Services Operates as NPO that offers healthcare products | Commercial Services |
Genprex, Inc.
 Genprex, Inc. Pharmaceuticals: MajorHealth Technology Develops molecular therapies for cancer treatment | Health Technology |
George Washington University
 George Washington University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Drug Information Association
Drug Information Association Miscellaneous Commercial ServicesCommercial Services Operates as non-profit multidisciplinary association for health and well-being | Commercial Services |
American Academy of Pharmaceutical Physicians | |
Capital City Technical Consulting, Inc. | |
The Foundation For Sickle Cell Research |
